tiprankstipranks
Trending News
More News >
Bausch Health Companies (TSE:BHC)
TSX:BHC
Canadian Market

Bausch Health Companies (BHC) Ratios

Compare
154 Followers

Bausch Health Companies Ratios

TSE:BHC's free cash flow for Q1 2025 was $0.69. For the 2025 fiscal year, TSE:BHC's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.08 1.30 1.08 1.08 1.09
Quick Ratio
0.80 0.94 0.80 0.89 0.86
Cash Ratio
0.14 0.22 0.14 0.11 0.12
Solvency Ratio
0.05 0.02 0.05 0.02 0.04
Operating Cash Flow Ratio
-0.18 0.24 -0.18 0.27 0.23
Short-Term Operating Cash Flow Coverage
-1.69 2.29 -1.69 0.00 0.00
Net Current Asset Value
$ -21.18B$ -21.84B$ -21.18B$ -23.63B$ -25.25B
Leverage Ratios
Debt-to-Assets Ratio
0.81 0.82 0.81 0.78 0.77
Debt-to-Equity Ratio
-30.01 -21.91 -30.01 -213.72 44.72
Debt-to-Capital Ratio
1.03 1.05 1.03 1.00 0.98
Long-Term Debt-to-Capital Ratio
1.04 1.05 1.04 1.00 0.98
Financial Leverage Ratio
-37.12 -26.76 -37.12 -275.49 58.32
Debt Service Coverage Ratio
1.47 1.11 1.47 2.35 2.29
Interest Coverage Ratio
0.94 0.73 0.94 0.85 0.44
Debt to Market Cap
9.15 7.66 9.15 2.29 3.26
Interest Debt Per Share
61.41 64.99 61.41 67.09 71.83
Net Debt to EBITDA
7.02 9.74 7.02 6.77 7.43
Profitability Margins
Gross Profit Margin
70.90%70.78%70.90%71.61%71.98%
EBIT Margin
16.43%10.71%16.43%4.77%7.47%
EBITDA Margin
35.43%25.15%35.43%38.65%39.09%
Operating Profit Margin
16.86%11.00%16.86%14.35%8.42%
Pretax Profit Margin
-1.59%-4.45%-1.59%-12.14%-11.64%
Net Profit Margin
-2.61%-6.76%-2.61%-11.11%-6.96%
Continuous Operations Profit Margin
-2.61%-6.98%-2.61%-11.11%-6.96%
Net Income Per EBT
164.34%151.79%164.34%91.50%59.85%
EBT Per EBIT
-9.42%-40.50%-9.42%-84.63%-138.17%
Return on Assets (ROA)
-0.83%-2.16%-0.83%-3.21%-1.79%
Return on Equity (ROE)
30.64%57.93%30.64%883.96%-104.49%
Return on Capital Employed (ROCE)
6.30%4.18%6.30%5.04%2.57%
Return on Invested Capital (ROIC)
10.13%6.40%10.13%4.60%1.54%
Return on Tangible Assets
-2.54%-6.10%-2.54%-9.56%-5.76%
Earnings Yield
-9.34%-20.24%-9.34%-9.45%-7.61%
Efficiency Ratios
Receivables Turnover
4.54 4.38 4.54 4.75 5.09
Payables Turnover
4.54 3.56 4.54 5.88 6.67
Inventory Turnover
2.17 1.66 2.17 2.41 2.06
Fixed Asset Turnover
5.08 4.63 5.08 5.28 5.12
Asset Turnover
0.32 0.32 0.32 0.29 0.26
Working Capital Turnover Ratio
22.72 10.95 22.72 20.13 13.96
Cash Conversion Cycle
168.28 200.95 168.28 166.16 194.57
Days of Sales Outstanding
80.42 83.28 80.42 76.82 71.71
Days of Inventory Outstanding
168.30 220.23 168.30 151.40 177.55
Days of Payables Outstanding
80.44 102.55 80.44 62.05 54.69
Operating Cycle
248.72 303.51 248.72 228.21 249.26
Cash Flow Ratios
Operating Cash Flow Per Share
-2.01 2.83 -2.01 3.97 3.13
Free Cash Flow Per Share
-2.75 2.08 -2.75 3.18 2.26
CapEx Per Share
0.74 0.75 0.74 0.79 0.87
Free Cash Flow to Operating Cash Flow
1.37 0.74 1.37 0.80 0.72
Dividend Paid and CapEx Coverage Ratio
-2.72 3.79 -2.72 5.04 3.60
Capital Expenditure Coverage Ratio
-2.72 3.79 -2.72 5.04 3.60
Operating Cash Flow Coverage Ratio
-0.04 0.05 -0.04 0.06 0.05
Operating Cash Flow to Sales Ratio
-0.09 0.12 -0.09 0.17 0.14
Free Cash Flow Yield
-43.88%25.99%-43.88%11.53%10.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-10.71 -4.94 -10.71 -10.58 -13.14
Price-to-Sales (P/S) Ratio
0.28 0.33 0.28 1.18 0.92
Price-to-Book (P/B) Ratio
-3.28 -2.86 -3.28 -93.53 13.73
Price-to-Free Cash Flow (P/FCF) Ratio
-2.28 3.85 -2.28 8.67 9.16
Price-to-Operating Cash Flow Ratio
-3.12 2.83 -3.12 6.95 6.61
Price-to-Earnings Growth (PEG) Ratio
0.14 -0.03 0.14 -0.16 0.19
Price-to-Fair Value
-3.28 -2.86 -3.28 -93.53 13.73
Enterprise Value Multiple
7.81 11.07 7.81 9.81 9.77
Enterprise Value
22.47B 24.37B 22.47B 31.99B 30.67B
EV to EBITDA
7.81 11.07 7.81 9.81 9.77
EV to Sales
2.77 2.78 2.77 3.79 3.82
EV to Free Cash Flow
-22.56 32.06 -22.56 27.98 38.24
EV to Operating Cash Flow
-30.87 23.61 -30.87 22.43 27.60
Tangible Book Value Per Share
-47.20 -48.56 -47.20 -54.16 -58.92
Shareholders’ Equity Per Share
-1.91 -2.80 -1.91 -0.30 1.51
Tax and Other Ratios
Effective Tax Rate
-0.64 -0.57 -0.64 0.08 0.40
Revenue Per Share
22.44 24.00 22.44 23.50 22.65
Net Income Per Share
-0.59 -1.62 -0.59 -2.61 -1.58
Tax Burden
1.64 1.52 1.64 0.92 0.60
Interest Burden
-0.10 -0.42 -0.10 -2.55 -1.56
Research & Development to Revenue
0.07 0.07 0.07 0.06 0.06
SG&A to Revenue
0.26 0.26 0.26 0.25 0.24
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.02 0.01
Income Quality
3.43 -1.69 3.43 -1.52 -1.99
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis